Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Coulet

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Genetic Testing and Molecular Biomarkers|September 23, 2010
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysisFlorence Coulet, Filipe Pires, Etienne Rouleau, et al.
European Journal of Medical Genetics|October 15, 2020
MUTYH-associated polyposis: Review and update of the French recommendations established in 2012 under the auspices of the National Cancer institute (INCa)Chrystelle Colas, Valérie Bonadona, Stéphanie Baert-Desurmont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2026
Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancerAmelia Favier, Julia Le Tan, Aurélie Siret, et al.
Bulletin Du Cancer|May 5, 2020
[MUTYH-associated polyposis: Review and update of the French recommendations established in 2012 under the auspices of the National Cancer Institute (INCa)]Marie-Pierre Buisine, Valérie Bonadona, Stéphanie Baert-Desurmont, et al.
Human Mutation|March 17, 2004
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in FranceGaëtan Lesca, Henri Plauchu, Florence Coulet, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
European Journal of Medical Genetics|November 13, 2020
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemicPatrick R Benusiglio, Clément Korenbaum, Roseline Vibert, et al.
Nature Genetics|December 3, 2013
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertensionMélanie Eyries, David Montani, Barbara Girerd, et al.
The European Respiratory Journal|December 25, 2015
Genetic counselling in a national referral centre for pulmonary hypertensionBarbara Girerd, David Montani, Xavier Jaïs, et al.
Chest|November 28, 2014
Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2Barbara Girerd, Florence Coulet, Xavier Jaïs, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Genetic Testing and Molecular Biomarkers|September 23, 2010
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysisFlorence Coulet, Filipe Pires, Etienne Rouleau, et al.
European Journal of Medical Genetics|October 15, 2020
MUTYH-associated polyposis: Review and update of the French recommendations established in 2012 under the auspices of the National Cancer institute (INCa)Chrystelle Colas, Valérie Bonadona, Stéphanie Baert-Desurmont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2026
Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancerAmelia Favier, Julia Le Tan, Aurélie Siret, et al.
Bulletin Du Cancer|May 5, 2020
[MUTYH-associated polyposis: Review and update of the French recommendations established in 2012 under the auspices of the National Cancer Institute (INCa)]Marie-Pierre Buisine, Valérie Bonadona, Stéphanie Baert-Desurmont, et al.
Human Mutation|March 17, 2004
Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in FranceGaëtan Lesca, Henri Plauchu, Florence Coulet, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2010
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutationBarbara Girerd, David Montani, Florence Coulet, et al.
European Journal of Medical Genetics|November 13, 2020
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemicPatrick R Benusiglio, Clément Korenbaum, Roseline Vibert, et al.
Nature Genetics|December 3, 2013
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertensionMélanie Eyries, David Montani, Barbara Girerd, et al.
The European Respiratory Journal|December 25, 2015
Genetic counselling in a national referral centre for pulmonary hypertensionBarbara Girerd, David Montani, Xavier Jaïs, et al.
Chest|November 28, 2014
Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2Barbara Girerd, Florence Coulet, Xavier Jaïs, et al.
Pageof 12